Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark

Showing results (1161-1170 of 1,377) with videos related to

Pageof 138
Sort By:
Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.
Molecular Cancer|October 4, 2008
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinomaEric Smith, Neville J De Young, Sandra J Pavey, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
Circulation|October 26, 2011
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarctionJudith S Hochman, Harmony R Reynolds, Vladimír Dzavík, et al.
American Heart Journal|March 20, 2012
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)Harmony R Reynolds, Sandra A Forman, Jacqueline E Tamis-Holland, et al.
JAMA|December 7, 2006
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantationEric L Eisenstein, Kevin J Anstrom, David F Kong, et al.
Journal of Medicinal Chemistry|November 28, 2019
An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt InhibitorsWen Zhang, Vitaliy M Sviripa, Liliia M Kril, et al.
Nature Medicine|July 17, 2020
Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney diseaseJennifer S Lees, Claire E Welsh, Carlos A Celis-Morales, et al.
Pageof 138

Showing results (1161-1170 of 1,377) with videos related to

Sort By:
Pageof 138
Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.
Molecular Cancer|October 4, 2008
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinomaEric Smith, Neville J De Young, Sandra J Pavey, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
Circulation|October 26, 2011
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarctionJudith S Hochman, Harmony R Reynolds, Vladimír Dzavík, et al.
American Heart Journal|March 20, 2012
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)Harmony R Reynolds, Sandra A Forman, Jacqueline E Tamis-Holland, et al.
JAMA|December 7, 2006
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantationEric L Eisenstein, Kevin J Anstrom, David F Kong, et al.
Journal of Medicinal Chemistry|November 28, 2019
An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt InhibitorsWen Zhang, Vitaliy M Sviripa, Liliia M Kril, et al.
Nature Medicine|July 17, 2020
Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney diseaseJennifer S Lees, Claire E Welsh, Carlos A Celis-Morales, et al.
Pageof 138